Bianca Kenyon, MD
Vascular Surgery · Manassas, VANPI 1609293836
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $2,873 of the $3,763 with a category attached, or 76.3%. 17 manufacturers reported payments, led by W. L. Gore & Associates, Inc. at 37.7% of the total. That places this record below the midpoint for vascular surgery clinicians in VA, where the typical reported total is $4,916.
Across 32 payments — averaging $117.60 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- W. L. Gore & Associates, Inc.$1K
- Abbott$388
- TELA Bio, Inc.$342
- Medtronic$314
- Endologix LLC$303
- Silk Road Medical, Inc.$176
- plus $822 from 11 others
What the payments were for
- Travel & lodging$89024%
- Food & beverage$2,87376%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| W. L. Gore & Associates, Inc. | 8 | $1,417 |
| Abbott | 3 | $388 |
| TELA Bio, Inc. | 4 | $342 |
| Medtronic | 3 | $314 |
| Endologix LLC | 1 | $303 |
| Silk Road Medical, Inc. | 2 | $176 |
| Acell, Inc. | 1 | $125 |
| Lilly USA, LLC | 1 | $125 |
| Ionis Pharmaceuticals, Inc. | 1 | $122 |
| Novo Nordisk | 1 | $119 |
| Bayer | 1 | $119 |
| Boston Scientific | 1 | $113 |
| Recor Medical Inc | 1 | $28 |
| Pfizer | 1 | $22 |
| Cvrx, Inc. | 1 | $19 |
| Scpharmaceuticals Inc. | 1 | $15 |
| Novartis | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$3,763 in reported general payments places this provider in the 40th percentile of 143 vascular surgery providers in Virginia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Oxycodone Hcl | 20 | $102 |
| Atorvastatin Calcium | 13 | $101 |
Paid to pharmacies, not to this prescriber.
Other vascular surgery in Manassas
- Behdad AryavandManassas$39K
- Jean PannetonVirginia Beach$1.3M
- John DeitrickRichmond$684K
- Rasesh ShahChesapeake$465K
- David DexterNorfolk$404K
- Samuel SteermanVirginia Beach$252K
- Joseph BabrowiczFairfax$202K
- Joshua AdamsRoanoke$138K
- Richard NevilleFalls Church$114K
- Anthony ComerotaFalls Church$107K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.